TORONTO, Nov 15 (Reuters) – Toronto’s main stock index was
slightly higher on Monday morning as banks led a broad rebound
from Friday’s selloff, but a decline by Potash Corp (POT.TO: Quote, Profile, Research, Stock Buzz)
TORONTO, Nov 9 (Reuters) – Troubled Canadian biotech
company Angiotech Pharmaceuticals Inc (ANP.TO: Quote, Profile, Research, Stock Buzz) said it had
entered into a temporary loan agreement to carry it through to
its planned recapitalization, as it reported a wider quarterly
loss on Tuesday.
Late last month, the maker of specialty pharmaceuticals and
medical devices announced a recapitalization plan that would
cut its debt by $250 million, or just under half the total.
TORONTO, Nov 8 (Reuters) – Amazon.com’s (AMZN.O: Quote, Profile, Research, Stock Buzz) Canadian
site has added skates, snowboards and outdoor gear to its
traditional line up of books, music and DVDs, posing a small
but perhaps growing threat to retailers like Canadian Tire
(CTC.TO: Quote, Profile, Research, Stock Buzz) and Forzani Group (FGL.TO: Quote, Profile, Research, Stock Buzz).
Analysts say the Canadian market is small for the online
retailing giant — only about 5 percent of revenue compared to
50 percent from the U.S. division.
TORONTO, Nov 3 (Reuters) – Canadian pharmaceutical company
QLT Inc (QLT.TO: Quote, Profile, Research, Stock Buzz) posted a quarterly loss and cut its full-year
sales outlook, hurt by weaker performance of its key eye
Sales of Visudyne, the No. 3 treatment for age-related
macular degeneration, have dropped steadily in the face of
increased competition, but QLT indicated during a conference
call the decline appeared to be slowing.
TORONTO (Reuters) – Casey’s General Stores Inc (CASY.O: Quote, Profile, Research, Stock Buzz) rejected a $43-a-share offer by 7-Eleven and ended talks with the convenience store operator owned by Japan’s Seven & I Holdings (3382.T: Quote, Profile, Research, Stock Buzz), two months after a second rejected suitor walked away.
Shares of Casey’s dropped nearly 8 percent on the Toronto Stock Exchange before recovering slightly, but were still down nearly 5 percent by midafternoon.
TORONTO, Nov 2 (Reuters) – Lululemon Athletica (LLL.TO: Quote, Profile, Research, Stock Buzz)
(LULU.O: Quote, Profile, Research, Stock Buzz), one of a rare breed of Canadian retailers that has
successfully expanded into the United States, may have more
room to grow in the $15 billion women’s fitness apparel
Affluent women willing to fork over $100 for yoga pants or
$60 for a tank-top have helped the high-flying Canadian company
wallop quarterly earnings expectations and drive same-store
sales up 31 percent. That’s nearly unparalleled in a soft
retail environment where many chains are closing stores, not
opening new ones.
TORONTO, Oct 1 (Reuters) – Canadian e-reading service
provider Kobo Inc hopes to find success riding on the back of
the BlackBerry PlayBook and other tablet computers even as it
continues to expand its own line up of e-readers.
Kobo, a nine-month-old spinoff of Canadian book retailer
Indigo Books & Music (IDG.TO: Quote, Profile, Research, Stock Buzz), is looking to leap ahead in the
e-book market by trying to become the standard e-reading source
on tablets and smartphones.
TORONTO, Sept 30 (Reuters) – Canada’s Alimentation
Couche-Tard (ATDb.TO: Quote, Profile, Research, Stock Buzz) abandoned its $2 billion hostile takeover
bid for Casey’s General Stores (CASY.O: Quote, Profile, Research, Stock Buzz) on Thursday, nearly
half a year after it made its initial offer for the U.S.
convenience store chain.
Couche-Tard, Canada’s largest convenience store operator,
has looked to expand in the United States and add Casey’s
1,500-plus U.S. Midwest stores to its network of 5,800 North
TORONTO, Sept 27 (Reuters) – A deal with Russia’s Rosatom
is expected to provide MDS Nordion (MDS.TO: Quote, Profile, Research, Stock Buzz) with a key medical
isotope for at least the next 10 years, but the move is not
intended as a permanent replacement for supplies from an aging
Canadian reactor, the company said on Monday.
MDS, one of the world’s largest providers of medical
isotopes — used in cancer testing and other procedures –
spoke with analysts on Monday after signing a framework
agreement last week with Rosatom State Corp, a state-owned
TORONTO (Reuters) – Two California legislators have asked U.S. authorities to re-examine a proposed $3.3 billion merger between U.S.-based Valeant Pharmaceuticals International and Canada’s Biovail Corp, days before shareholders are to vote on the deal.
In separate letters, assemblymen Kevin de Leon and Jared Huffman asked the Securities and Exchange Commission and the U.S. Department of Justice to look again at the deal which has already received regulatory approvals.